Mason Street Advisors’s Exact Sciences EXAS Stock Holding History

Mason Street Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-368,750	Closed	-$5.13M	–	1761
2013 Q2	$5.13M	Buy	+368,750	New	+$4.01M	0.06%	365

Other funds holding EXAS

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Mason Street Advisors's EXAS Position: Q3 2013 in Review

Mason Street Advisors sold out of Exact Sciences (EXAS) in Q3 2013, closing a stake of 368,750 shares — an estimated $5.13M sold.

Mason Street Advisors first reported a position in EXAS in Q2 2013 and held it in 1 quarter. The position peaked at $5.13M in Q2 2013. 129 funds tracked by Wall St. Rank hold EXAS as of Q3 2013.

Mason Street Advisors reported no remaining Exact Sciences position as of Q3 2013 after selling out during the quarter.
Mason Street Advisors sold 368,750 Exact Sciences shares in Q3 2013, an estimated $5.13M.
Mason Street Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 1 quarter.
Mason Street Advisors's Exact Sciences position peaked at $5.13M in Q2 2013.
129 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2013.

Based on Mason Street Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.